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Induction of protective immunity to 
Theileria anndata using two major 
merozoite surface antigens presented 
by different delivery systems 
Christine d’Oliveira*, Andries Feenstra”, Helma Vos”f, 
Albert D.M.E. Osterhaust, Brian R. ShielsS, Albert W.C.A. Cornelissen” 
and Frans Jongejan” 8 
Allelic forms (Tamsl-1 and Tamsl-2) of the major merozoite surface antigen gene of 
Theileria annulata have recently been expressed in Escherichia coli and in Salmonella 
typhimurium aroA vaccine strain SL3261. To test the potential of subunit vaccines 
against T. annulata infection, we immunized four groups of three calves with either 
recombinant (re-) (Tamsl-1 and Tamsl-2) proteins or naked DNA encoding these 
antigens. Group I was immunized intramuscularly with both re-proteins incorporated 
into immunostimulating complexes (ISCUMs). Group II was inoculated intramuscu- 
larly with naked plasmid DNA encoding Tamsl-1 and Tamsl-2. Groups III and IV 
received S. typhimurium SL3261 [pSTamsl-l][pIPS] and SL3261[pSTamsI-2][pIP5] 
subcutaneously and orally, respectively. A final group of three animals (Group V) 
served as an unimmunized control group. Four weeks after the last immunization all 
calves were challenged with a T. annulata stabilate generated from blood of an 
infected animal with 30% piroplasm parasitaemia. All calves vaccinated with ISCOMs 
proved to be protected from T. annulata infection and had generated antibodies 
against both re-(Tamsl-1 and Tamsl-2) at the time of challenge. In two of these 
animals the antibody had a surface binding profile by IFAT. Two of three calves 
immunized with naked DNA also proved to be protected, but none of the animals had 
generated any detectable antibodies against the recombinants. Salmonella-based 
delivery of the recombinants did not induce any protection; two of six animals died of 
theileriosis and there was no difference between subcutaneous or oral administration 
These preliminary results show that re- (Tamsl-1 andlor Tams1 -2) may elicit protective 
immune responses in cattle, depending on the antigen delivery system. 0 1997 Elsevier 
Science Ltd. 
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The protozoan parasite Theiletia annulata infects cattle 
and domestic buffalo (Bubalus b&a/is) across an area 
stretching from southern Europe and northern Africa, 
through the Middle East and southern Russia into 
India and southern China’. T anndata is transmitted 
by ticks of the genus Hyafomma and more than 250 
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million domestic cattle have been estimated to be at 
risk from tropical theileriosis’. Infection in the bovine 
is initiated by inoculation of sporozoites from infected 
ticks during feeding. These invade mononuclear leuco- 
cytes (thought primarily to be monocytes and B-cells 
expressing MHC class II antigens”.4), where they 
develop into multinucleated macroschizonts and induce 
host cells to divide in synchrony with the macroschi- 
zont. These parasites develop further from microschi- 
zonts into free merozoites, which upon release from 
the leucocyte invade erythrocytes to develop into 
piroplasms. 
Tropical theileriosis is currently controlled by 
chemotherapy, tick control using acaricides and vaccin- 
ation using attenuated macroschizont-infected 
lymphoid cell lines. Although these live vaccines are 
being used with success in endemic areas’-“‘, their 
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application has a number of drawbacks. The vaccine 
lines need to be evaluated for their ability to protect 
against challenge, require prolonged in vitro passage to 
become attenuated and it is not clear whether attenu- 
ated cells can revert to virulence in vivo. Such 
prolonged passage can also lead to lines losing their 
ability to immunize recipient animals as a result of the 
inability of the macroschizonts to transfer into the cells 
of the vaccinated animal. Furthermore, although cattle 
are protected by the attenuated cell line vaccine, it 
does not prevent the development of the erythrocytic 
stages when animals are challenged”. In addition, once 
thawed the vaccine has a short half life and there is the 
possibility of transferring other pathogens by the use of 
such live vaccines. Many of these limitations could be 
overcome by the production of immunogenic antigens 
by re-DNA techniques and development of a subunit 
vaccine against ropical theileriosis. 
One antigen (SPAG-1) has been identified on the 
surface of the sporozoite by a mAb which blocks sporo- 
zoitc penetration of bovine peripheral blood 
mononuclear cells in vitro”. A C-terminal fragment 
(SRI) of SPAG-I has been expressed as a fusion 
protein in the el loop of hepatitis B core antigen 
(HBcAg) and used to immunize calves in a small scale 
vaccination trial. High antibody titres were generated 
in all four animals immunized with HBcAg-SRI and 
IFAT confirmed that there was recognition of the 
sporozoite surface. Clinical symptoms were delayed on 
sporozoite challenge; however, all the animals 
eventually developed disease”. 
The merozoite stage is, like the sporozoite, invasive 
and also a potential target for a protective immune 
response. Recently, allelic forms of Tams1 (TurnsI- 
and Tumsl-2) which encode the 30 kDa and 32 kDa 
major merozoite surface antigens of 7: annufutu, 
respectively, have been expressed in a Salmonella typhi- 
murium aroA vaccine strain and Escherichia coli”. 
Immunostimulating complexes (ISCOMs) were 
prepared from both recombinants purified from E. coli. 
As a third route to deliver re-(Tamsl-1 and Tamsl-2) 
to the bovine host, both genes were subcloned into an 
eukaryotic expression vector and used as a DNA 
vaccine. In this paper we evaluate the potential of 
these three systems as a component of a multistage 
subunit vaccine against ropical theileriosis in cattle. 
MATERIALS AND METHODS 
Bacterial strains and culture 
Escherichia coli MlS[pREP4]‘” and Salmonella typhi- 
murium SL3261” producing re-(Tamsl-1 or Tams1 -2) 
were grown as described previouslyi4. S. typhimurium 
SL3261 [pSTamsl-l][pIPS] and SL3261[pSTamsl- 
2]]pIP5] used for animal experiments were washed in 
PBS and each was resuspended at 1 x IO9 ml -’ and 
2 x IO”’ ml ’ for subcutaneous and oral administration, 
respectively. The bacteria were checked for the correct 
aro, his, ApR and KmR phenotypes by selection on 
appropriate minima1 plates” with or without 10 pg ml-’ 
para-aminobenzoic acid; 10 1.18 ml-’ 2,3_dihydroxyben- 
zoic acid, 40 pg,rnl~ phenylalanine, 40 pg ml ’ 
tyrosine, 40 /Lg ml histidine, 40 pg ml -’ tryptophan, 
and by culture on LB plates supplemented with 
100 pg ml ’ ampicillin (Ap) and 25 pg ml-’ kanamycin 
(Km). To distinguish S. typhimurium from E. coli, 
growth was tested on brilliant green agar (BGA) 
plates. Smooth LPS phenotype was determined by 
examining LPS profiles on silver-stained gels’“. Briefly, 
whole cell lysates were boiled for 10 min, incubated 
with 125 ;lg proteinase K at 60°C for 1 h and subse- 
quently examined by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) 
followed by silver staining. S. typhimurium-Smooth and 
-Rough (ATCC 14028) kindly provided by Dr J.G. 
Kusters, and E. coli were used as controls. 
Preparation of ISCOMs containing re-(Tamsl-1 or 
Tamsl-2) 
Production and isolation from E. coli 
MlS[pETamsl-1 +][pREP4] and MlS[pETamsl- 
2+][pREP4] of re-(Tamsl-1 and Tamsl-2) respec- 
tively, were performed as described previously’4. For 
the preparation of ISCOMs, recombinants were mixed 
separately with cholesterol, phosphatidylcholine (Sigma 
Chemical Co., St. Louis, MO, USA) and Quil A 
(Spikoside, Iscotec, Lulea, Sweden) at a ratio of 1:1:5 
(w/w/w). After ultrasonic treatment for 10min the 
mixture was incubated for 1 h at room temperature. 
Subsequently, the mixture was extensively dialysed 
against 10 mM Tris-HCI (pH 7.4) 0.3 M NaCl, layered 
over a linear (lo-60%) sucrose gradient and centri- 
fuged for 18 h at 25 K (Beckmann SW28 rotor). 
Fractions containing peak levels of the recombinants 
(coinciding with the presence of ISCOM-like struc- 
tures, as judged by negative contrast electron micros- 
copy) were pooled. For SDS-PAGE and subsequent 
Western blotting, ISCOMs were pelleted by ultracen- 
trifugation for 4 h at 40 K and resuspended in PBS 
(l/l 0 of the initial volume). 
Cloning of Tamsl-l and Tamsl-2 in pSLRSV.Nul 
Primers for PCR were chosen which were comple- 
mentary to conserved sequences flanking Tamsl-l and 
Tamsl-2. Primer 1: 5’-GGAATTAGATCTfiTTGT- 
CCAGGACCACC-3’ and primer 2: 5’-AATICCA- 
GATCTGGGTT-MGGAAGTAAAGG-3’. BglII 
restriction sites (presented in bold) were incorporated 
to facilitate subsequent cloning. The positions of the 
start and stop codons are underlined in primer 1 and 
primer 2, respectively. PCR was performed in a final 
reaction volume of 100 ~1 containing 50 mM KC], 
10 mM Tris-HC1 (pH 8.3) 0.1% Triton X-100, 1.5 mM 
MgCl?, 200 !cM (each) deoxynucleoside triphosphate, 
80 pmol of each primer, 2.5 U Tuq polymerase 
(Promega, Madison, WI, USA) and 10 ng of plasmid 
DNA containing Tamsl-l or Tams]-2. Reactions were 
performed in an automatic DNA thermal cycler 
(Perkin-Elmer, Foster City, CA, USA) for 30 cycles 
comprising denaturation at 94°C for 1 min, annealing 
at 55°C for 1 min and extension at 72°C for 1 min. The 
resulting 851-bp fragments were separated by electro- 
phoresis on a 1.2% low-melting point agarose gel and 
isolated using QiaexII (Qiagen, Chatsworth, CA, 
USA). These fragments containing the complete 
coding sequence of Tumsl-l and Tamsl-2, were ligated 
into expression vector pSLRSV.Nul, digested with 
BglII and treated with Calf-Intestinal-Phosphatase”. 
Plasmid pSLRSV.Nul/BglII-version was kindly 
provided by Prof. L. Babiuk and modified by Dr J. 
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Lewis (personal communication)‘g-“. The resulting 
plasmids pBglII30 and pBglII32 contained the 30 kDa 
and 32 kDa merozoite surface antigen coding 
sequences, respectively, both under control of the Rous 
Sarcoma Virus-Long Terminal Repeat promoter and 
the SV-40 polyadenylation signal. The plasmid 
backbone was derived from pSL301TM (Invitrogen, San 
Diego, CA, USA). Both plasmids were purified from E. 
coli DHSa using Qiagen columns (Qiagen) and verified 
by nucleotide sequence analysis”. 
Immunizations 
neck. 
Experimental calves (Bos ~CIUTCIS), 5-6 months of age 
and kept in experimental tick-proof pens were used in 
the experiments. Fifteen calves were allocated 
randomly into five groups of three animals each and 
immunized according to the schedule summarized in 
Table I. Each immunization consisted of two prepara- 
tions: one contained re-(Tamsl-l), given on the right- 
hand side in the neck of the animal, and the other 
contained re-(Tamsl-2), given on the left-hand side in 
the 
(I) 
(2) 
(3) 
(4) 
(5) 
Group I: 1 ml ISCOM vaccine given intramuscu- 
larly, containing 20 /lg re-(Tamsl-l or Tams1 -2); 
Group II: 1 ml DNA vaccine given intramuscularly, 
containing 500 pg of pBglI130 or pBglI132 
dissolved in TE [lo mM Tris-HCI (pH 8), 1 mM 
EDTA]; 
Group III: 1 ml Salmonella vaccine given subcutan- 
eously, containing 1x10” S. typhimurium 
SL3261[pSTamsl-l][pIPS] or SL3261[pSTamsl- 
21[~1p51; 
Group IV: 5 ml Salmonella vaccine given orally, 
containing 1 x IO” S. typhimurium SL3261- 
[pSTamsl-l][pIPS] or SL3261[pSTamsl-2][pIP5]; 
Group V: three unimmunized control calves were 
infected with T. annulclta only. 
Rectal temperatures were taken daily and blood was 
collected weekly for sera analysis. Additional blood 
samples were collected three times weekly in citrate 
buffer for the preparation of blood smears and deter- 
mination of packed cell volume (PCV). The remainder 
of the blood sample was stored at -20°C for PCR 
analysis. 7: annuluta piroplasms were counted in 
Giemsa-stained blood smears. When very scanty, their 
presence was confirmed by PCR and subsequently 
Southern hybridization using Tamsl-I cDNA as a 
probe, as described previously’4. Blood samples for 
PCR were collected from Groups I and II prior to 
challenge and in weeks 2, 3, 4, 8 and 12 postchallenge. 
Saponin lysis mix (0.22% NaCl, 0.015% saponin, 1 mM 
EDTA) was added to 50 /II of blood and the mixture 
was centrifuged for 1 min. Pellets were washed three 
times with saponin lysis mix, resuspended in 100 ![I 
PCR buffer (50 mM KCI, 10 mM Tris-HCI (pH 8) 
0.5% Tween 20, 100 /lg proteinase K mll ) and 
incubated at 56°C for 1 h. After 10 min at 95°C 5 it1 
were used for PCR, performed as described above. 
Challenge 
Calf 184 was experimentally infected with 7: annulatu 
(Ankara, Turkey)-” administered as a ground-up tick 
supernate, kindly provided by Prof. C.G.D. Brown. 
When the parasitaemia (piroplasms) reached 30%, 
blood was frozen with 10% DMSO in 2 ml aliquots at 
-80°C representing approximately 6 x 10’ piroplasms 
per aliquot, plus an unknown number of macroschi- 
zont-infected leucocytes. Control and immunized 
animals were challenged with this stabilate admini- 
stered subcutaneously (1 ml) and intravenously (1 ml) 
in the neck of the animal (Tuhle I). 
Western blotting 
Column-purified re-(Tamsl-1 and Tamsl-2) and 
proteinase K-digested whole cell lysates of S. typhimu- 
rium SL3261 were separated by 0.1% SDS-12% 
PAGE”. Purified S. typhimurium LPS (Sigma) was 
used as a control. Subsequently, Western blot analysis 
was performed using preimmune, prechallenge and 
postchallenge sera from immunized calves at a 1:lOO 
dilution and, as a control, rabbit anti-LPS serum, 
kindly provided by Edwin J. Tijhaar. Pelleted ISCOMs 
were separated and the Western blot analysed as 
described above, using immune serum from calf 184. 
Ab-Ag complexes were visualized using ECL immuno- 
detection (Amersham, Buckinghamshire, UK). 
Indirect immunofluorescent antibody assay 
7: armulata (Ankara, Turkey)ls piroplasm infected 
erythrocytes were prepared by centrifugation of blood 
at SOOg for 10 min. Pelleted cells were washed twice in 
PBS, resuspended to a density of approximately 
3 x 10’ ml-’ and fixed in acetone at - 20°C for 20 min. 
The indirect antibody test was carried out essentially as 
described by Minami et ~1.‘~. Briefly, sera isolated at 
the time of challenge from ISCOM immunized animals 
(Group I) and control calf 476 (Group V) and at weeks 
2, 3 and 9 postchallenge were assayed by incubating 
20 111 of a 1:50 dilution (in PBSRO% horse serum) on 
each well at room temperature for 30 min, followed by 
washing three times with PBS. Fluorescein-conjugated 
rabbit anti-bovine IgG (Sigma) was added to each well 
and incubated for a further 30 min at room tempera- 
Table 1 Vaccination schedule for four groups of three calves each immunized with re-(Tamsl-1 and Tamsl-2) either prepared as ISCOMs, 
encoded on plasmid pBglll30 and pBglll32, respectively, or produced in S. typhirnurium vaccine strain SL3261 
Animal 
group Delivery system Route 
Week” 
0 1 4 5 a 12 
I 
II 
Ill 
IV 
V 
ISCOMs Intramuscular + + _ C 
pBglll30 and -32 Intramuscular + _ + _ + C 
Salmonella SL3261 Subcutaneous + + _ C 
Salmonella SL3261 Oral + + _ C 
Unimmunized control Intravenous and subcutaneous _ _ _ C 
“C, challenged with T. anndata 
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ture. After washing as above, slides were stained with 
0.1% Evans blue, mounted with 50% glycerol in PBS 
and examined by microscopy under UV illumination at 
x 500 magnitication”. 
RESULTS 
ISCOM immunized calves 
The characteristic age-like structure of the ISCOMs 
was confirmed by electron microscopy after negative 
staining (data not shown). After performing 
SDS-PAGE of the pelleted ISCOMs, Western blot 
analysis using 7: annulata immune calf serum revealed 
bands at approximately 32 kDa and 33 kDa (Figure 
I(A), lanes I and 2) confirming the presence of 
purified re-(Tamsl- 1) and re-(Tamsl-2) respectively 
(Figure Z(A), lanes 3 and 4). 
Group I calves were immunized twice with ISCOMs 
intramuscularly, with an interval of 4 weeks (Table I) 
and proved to be protected against 7: anndctu 
challenge (Tahlr 2). Western blot analysis revealed that 
all three animals had generated antibodies against 
B 
Figure 1 (A) Western blot analysis of re-(Tamsl-1 and Tamsl-2) 
ISCOMs (lanes 1 and 2, respectively) using T. annul&a immune 
serum, and Coomassie brilliant blue-stained re-Tamsl-1 and 
re-Tamsl-2 proteins run in parallel (lanes 3 and 4, respectively). 
(6) SDS-PAGE of S. typhimurium LPS stained with silver (lanes 1 
and 2) and Western blot analysed using rabbit anti-LPS serum 
(lanes 3 and 4). Lanes: 1, S. typhimurhm SL3261; 3, purified S. 
typhimufium LPS (Sigma) 
re-(Tamsl-l and Tamsl-2) at the time of challenge 
[Figure 2(A), lanes 1, 2, 5, 6, 9 and IO]. Although there 
were equal amounts of recombinant proteins loaded 
onto the gel [Figure I(A), lanes 3 and 41, the sera 
preferentially detected re-(Tamsl-2) [Figure 2(A), lanes 
2, 6 and lo], indicating that it was more immunogenic 
than the ISCOMs prepared from re-(Tams]-1) [Figure 
2(A), lanes 1, 5 and 91. Specific antibody levels were 
maintained in the sera of all three animals at least until 
week 23 postchallenge when the experiment was 
terminated [Figure 2(A), lanes 3, 4. 7. 8, 11 and 121, 
whereas the levels in control calf 476 (Group V) were 
almost non-detectable [Figure 2(A), lanes 15 and 161. 
Furthermore, sera taken at the time of challenge from 
calves 473 and 474 reacted with piroplasm antigen in 
IFAT, whereas serum from calf 475 showed a weak 
recognition (Figure 3). Sera taken from the three 
immunized and one control animal at week 9 postchal- 
lenge recognized the piroplasms and prcimmune sera 
did not react with tither the recombinants or 
piroplasms (data not shown). 
The protected animals (Nos. 473, 474 and 475) were 
confirmed to be 7: annuhta carriers by PCR (Figure 4 
and Southern hybridization [Figure 4(B)]. The expected 
778-bp fragment was amplified in all three animals at 
week 12 postchallenge [Figure 4(B), lanes 9 (after 
longer exposure), 15 and 221. Calf 475, which 
developed a maximum piroplasm parasitaemia of 1%~ 
was already positive by PCR at week 3 postchallenge 
(Figure 4, lane 19) and showed a profile similar to 
control calf 476 (Figure 4. lanes 23-28). Calf 474 
developed a 25% piroplasm parasitaemia in week 23 
postchallenge (Figure 4, lane 16) and was treated with 
ButalexrM (Mallinckrodt Veterinary, Uxbridge, UK) at 
a dose rate of 2.5 mg kg ’ body weight. 
Naked DNA immunized calves 
Group II was immunized three times intramuscularly 
at 4-week intervals using 500 /lg pBglII30 and 500 /lg 
pBglI132 in each immunization (Ehle I). SDS-PAGE 
and Western blot analysis with sera collected just 
before every boost or challenge did not reveal any 
detectable antibodies against the recombinants. Sera 
used at a 1:lO dilution instead of 1 :lOO was also 
Table 2 Induction of protective immunity to T. annulata in different groups of calves immunized with re-(Tamsl-1 and Tamsl-2) either 
oreoared as ISCOMs. encoded on plasmid pBglll30 and pBglll32, or produced in S. typhimurium vaccine strain SL3261 
Maximum values 
Group no. Calf no. Delivery system Temperature (“C) Parasitaemia (%) PCV reduction (%) Final outcome 
I 473 ISCOMs 39.2 <O.l 14 Protected 
474 39.1 <O.l 18 Protected” 
475 39.2 1 19 Protected 
II 519 Plasmid DNA 41.6 35 52 Theileriosisb 
520 40.8 1 18 Protected 
521 39.0 0.1 14 Protected 
Ill 3033 Salmonella S.C. 41 .o 8 56 Theileriosisb 
7643 41.5 8 49 Theileriosisb 
9263 41.9 50 78 Fatal theileriosis 
IV 7775 Salmonella oral 41.2 3 44 Theileriosisb 
1045 41.9 50 68 Fatal theileriosis 
4063 41.9 3 58 Theileriosis’ 
V 397 None 41.7 20 66 Theileriosis* 
403 41.8 18 57 Theileriosisb 
476 41.2 10 39 Theileriosisb 
aAnimal developed tropical theileriosis at week 23 postchallenge, and was treated with ButalexTM, dose rate 2.5 mg ml body weight 
bAnimal recovered without treatment 
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negative (data not shown). However, calves 520 and 
521 were protected, whereas calf 519 was not (Table 2). 
PCR analysis confirmed that all animals were carriers 
of 7: annulata (data not shown). 
Recombinant Salmonella immunized calves 
SL3261[pSTaml-1 or pSTamsl-2][pIPS] showed the 
characteristic pattern of smooth LPS after SDS-PAGE 
required by Salmonella for infecting host macrophages 
(data not shown). The at-o,4 and his deletions of 
SL3261[pSTamsl-1 or pSTamsl-2][pIP5], required for 
the avirulent Salmonella to be useful as vaccine, were 
confirmed by growth limited to minimal plates supple- 
mented with both the aromatic compounds and histi- 
dine. Growth of transformed SL3261 on LB containing 
both Ap and Km confirmed the presence of both 
pSTamsl-1 or pSTamsl-2 and PIPS. As an additional 
control, S. typhimurium and E. coli could be distin- 
guished on BGA plates. 
A 
12 34 
kDa ‘jr 
97- 
66- 
45- 
31- 
56 76 
Groups III and IV were immunized twice subcutan- 
eously and orally, respectively, with Salmonella 
producing re-(Tamsl-1 and Tamsl-2) (Table I). All 
animals developed fever accompanied by piroplasm 
parasitaemia. Calves 9263 (Group III) and 1045 
(Group IV) died of acute theileriosis. The other two 
animals from Group III developed a parasitaemia of 
8% whereas the two remaining animals from Group 
IV exhibited a maximum parasitaemia of 3%. Western 
blot analysis showed that all immunized animals had 
been infected with Salmonella at the time of challenge 
(Figures 2(B) and 2(C)). Sera from calves 9263 and 
1045 (both died subsequently) contained fewer 
antibodies against Salmonella LPS [F&MY 2(B), lanes 
11 and 12, Figure 2(C), lanes 7 and 8, respectively] in 
comparison with sera from animals that survived 
challenge [Figure 2(B), lanes 3, 4, 7 and 8, Figure 2(C), 
lanes 3, 4, 11 and 121. Furthermore, only calves 3033 
and 9263, both immunized subcutaneously, had gener- 
ated antibodies against re-Tamsl-1 and to a lesser 
9 10 1112 1314 1516 
B 
kDa 
12 34 56 76 9 IO 1112 
kDa 
12 34 
97- 
66- 
45- il 
31- (Z, 
56 76 9 10 11 12 
Figure 2 (A) Western blot analysis of re-Tarnsl-1 and re-Tamsl-2, respectively, using sera from ISCOM immunized calves (Group I) and 
control animal 476 (Group V). Lanes 1 and 2, serum from calf 473 at the time of challenge (t.c); lanes 3 and 4, week 23 postchallenge (p.c); 
lanes 5 and 6, calf 474 t.c; lanes 7 and 8, week 23 pc; lanes 9 and 10, calf 475 t.c; lanes 11 and 12, week 23 pc; lanes 13 and 14, calf 
476 preimmune serum; lanes 15 and 16, week 23 p.c (B) Western blot analysis of re-(Tamsl-1 and Tamsl-2) (lanes 1, 2, 5, 6, 9 and 10) 
and S. typhimurium LPS (lanes 3, 4, 7, 8, 11 and 12) using sera from recombinant Salmonella immunized calves (Group Ill, immunized 
subcutaneously). Lanes 1-4, serum from calf 3033; lanes 5-8, calf 7643; lanes 9-12, calf 9263. (C) As (8) using sera from recombinant 
Salmonella immunized calves (Group IV, immunized orally). Lanes l-4, calf 7775; lanes 5-8, calf 1045; lanes 9-12, calf 4063 
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Figure 3 lmmunofluorescence reactivity of antibodies generated at the time of challenge in ISCOM-immunized animals against acetone- 
fixed slide preparations of T. annulata (Ankara) piroplasms ( x 500). (A) Control mAb 5El; (6) calf 473; (C) calf 474; (D) calf 475 
A 
721 bp 
B 
0 
Figure 4 Agarose gel electrophoresis (A) and Southern blot hybridization using the c-DNA probe (B) of amplified DNA from calves 
immunized with iscoms (Group I) and control calf #476 (Group V) using primers 1 and 2. Lanes: 1, distilled water; 2, Tmnulata positive 
control; 3 and 29, molecular size markers (pBluescript[Stratagene, La Jolla, CA, USA] digested with Hinfl); 4 to 9, calf #473: 4, prior to 
challenge; 5, week 2 post-challenge; 6, week 3 post-challenge; 7, week 4 post-challenge; 8, week 8 post-challenge; 9, week 12 post- 
challenge; 10 to 16, calf #474: same as above, except an additional lane 16, week 23 post-challenge; 17 to 22, calf #475: same as above; 
23 to 28, ca/f #476: same as above. 
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extent against re-Tamsl-2 at the time of challenge 
[Figure 2(B), lanes 1, 2, 9 and lo]. Preimmune sera 
taken from the same animals did not react with either 
recombinant antigen or LPS (data not shown). As a 
control, anti-Salmonella LPS serum raised in rabbit 
reacted with Saimon&-LPS [Figure I(B), lanes 3 and 
41. 
DISCUSSION 
In the present paper we have shown the ability of 
re-(Tamsl-1 and/or Tamsl-2) to induce protective 
immunity in cattle against tropical theileriosis, using 
ISCOMs and naked DNA to deliver these antigens, 
whereas all three unimmunized control animals 
developed disease. Salmonella-based elivery did not 
induce any protection; in contrast, two of six animals 
died of tropical theileriosis. 
ISCOM immunized calves 
At the time of challenge, all three ISCOM 
immunized calves had generated antibodies which 
recognized the piroplasm by IFAT. The pattern of 
staining was identical to that detected by monoclonal 
5E1, which has been shown to bind to the surface of 
the merozoite”, suggesting that antibody generated 
against the ISCOMs results against the merozoite 
surface. Therefore, protection may have been due to 
high amounts of circulating antibodies to re-(Tamsl-1 
and Tamsl-2) which bind to the merozoite surface and 
prevent invasion of erythrocytes or opsonize the 
parasite for clearance in the spleen by macrophages. 
Serum from calf 475 showed a weak reaction in IFAT 
compared with the other two calves, which might be 
the reason why the animal developed a higher 
piroplasm parasitaemia (1%). To investigate the possi- 
bility of a Th-cell mediated immunity, a lymphocyte- 
stimulation assay will be used in further studies to 
characterize the phenotype of Th cells elicited by 
inoculation of re-(Tamsl-1 and/or Tamsl-2). 
Since ISCOMs were described by Morein et al.‘“, 
numerous studies have demonstrated their potential as 
a vaccine with built-in adjuvant properties. Bacterial, 
parasitic, viral and other proteins and peptides have 
been incorporated into ISCOMs to enhance the 
immune response in various ways, including activation 
of helper”” and cytotoxic”’ T cells and eneration of 
potent long-lasting antibody B responses. . Protection 
against lethal Toxoplasma gondii33, Trypanosoma cruzi34 
and Eimeria falcifotmis” infections has been induced in 
mice by immunization with ISCOMs containing one or 
several isolated parasite antigens. 
Naked DNA immunized calves 
Two of three naked DNA immunized calves were 
protected, although one had fever for 1 day accom- 
panied by a maximum piropiasm parasitaemia of 1%. 
There were no detectable antibodies generated against 
the recombinants, which suggests that protective 
immunity is dependent on T cells. Sedegah et a1.36 have 
shown 68% protection in mice against PZasmodium 
yoefii infection using plasmid DNA encoding the IT 
yoefii circumsporozoite protein, and that protection was 
dependent on CD8’ T cells. 
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Intradermal instead of intramuscular administration 
may improve the results3’. Skin-associated lymphoid 
tissues contain specialized cells that enhance immune 
responses, e.g. the dendritic cell and the macrophages 
of the dermis can also take up antigen and initiate 
immune responses. Therefore, the in vivo transfection 
of epidermal or dermal cells by DNA would be 
expected to provide a more efficient route for DNA 
immunization. A further improvement may be gene 
gun-based DNA immunization using a hand-held gene 
delivery instrument that requires > 5000-fold less 
DNA to induce similar responses via intramuscular or 
intradermal inoculation3’. 
Recombinant SufmoneIlu immunized calves 
None of the recombinant Salmonella immunized 
calves were protected, and two of the six animals died 
of tropical theileriosis. Only calves 3033 and 9263 had 
generated antibodies against re-(Tamsl-1 or Tamsl-2) 
at a relatively low level at the time of challenge and, in 
contrast to the ISCOM antisera, these were biased 
towards the re-Tamsl-1 protein. Moreover, calf 9263 
died of tropical theileriosis. This observation suggests 
that the recombinants were not produced at sufficient 
levels or in the appropriate form to induce adequate 
humoral and/or cell-mediated responses, possibly due 
to plasmid instability or toxicity of the recombinants in 
vivo. We recently reported that pSTamsl-1 or 
pSTamsl-2 and pIP5 can be maintained for at least 
48 h in S. typhimurium SL3261 in vitro14. Stabilization 
of antigen production could be further attained b 
Y insertion of the gene into the bacterial chromosome”. 
Also, Sadoff et af.39 have shown that the gene encoding 
the circumsporozoite (CS) antigen of I? bevghei when 
expressed in S. typhimurium can induce an antigen- 
specific cell-mediated immune response in mice and 
provided protection against sporozoite challenge in the 
absence of measurable antibody to CS protein. 
Control calves 
Group V animals received infected blood only and 
exhibited a very quick increase in piroplasm parasit- 
aemia (from 5 to 20% in 24 h). Furthermore, on 
Giemsa-stained blood smears no Maltese crosses were 
detected which are typical for division of piroplasms 
within erythrocytes. Instead, multiple piroplasm infec- 
tions were seen within individual erythrocytes, 
indicating the presence of macroschizont-infected 
leucocytes in the blood stabilate which differentiate to 
produce merozoites. This could be directly from 
infected cells within the stabilate or, more probably, 
following transfer of the schizont to the host cell of the 
immunized animal. Indeed, macroschizont-infected 
leucocytes could be detected in the spleen and liver of 
both animals that died. As it is known that Tamsl-I is 
produced by macroschizonts’” (at a low level) before 
differentiation to merozoites occurs, it is conceivable 
that peptides from these molecules are presented on 
the infected leucocyte together with MHC-I and recog- 
nized by cytotoxic T cells. Alternatively, the production 
of INF-y by Thl cells may activate macrophages and 
prevent the establishment of the macroschizont within 
leucocytes, as previously shown in vitro by Preston et 
a1.40 and Visser et al.“‘. As we did not obtain data on 
the T cell response in immunized animals, the 
induction of protective immunity to Theileria annulata: C. d’O/iveira et al. 
mechanism by which protection occurs is unclear at the 
present time. Further immunization trials are being 
conducted using ISCOMs with re-(Tamsl-1 and 
Tamsl-2) proteins combined with re-SPAG, and naked 
DNA encoding these proteins. Ultimately, it is likely 
that a subunit recombinant vaccine consisting of 
engineered antigens from sporozoites, schizonts as well 
as from merozoites/piroplasms will be necessary to 
induce protection against 7: annufutu infection, initi- 
ated through the bite of an infected tick. 
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